Public Calendar: March 29 - April 4, 2026
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 03/30/2026
Location: Virtual
Subject: Innovation in the Rare Disease Ecosystem
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Emil Kakkis (Ultragenyx);
Event Date: 03/30/2026
Location: Silver Spring, MD
Subject: Modernized Clinical Trial Endpoints for Accelerated Approval
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: American Society of Transplant Surgeons (ASTS) and American Society of Transplantation (AST) representatives
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Sean R. Keveney, J.D., Chief Counsel
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 03/30/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: SUSAN BERSOFF-MATCHA; MARK ABDOO; ROBERT FISHER; RAVI BHARWANI; MALLIKA MUNDKUR; MICHAEL DAVIS;
Non FDA Participant/Group: Kalah Auchincloss (Canal Row); Tom Hotchkiss, Zach Weinberg (Curio.Bio); Satish Gopal (National Institutes of Health / National Cancer Institute);
Event Date: 04/02/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: RAVI BHARWANI; MARK ABDOO; JOSEPH RIERAS;
Non FDA Participant/Group: Kathryn DiBitetto, Maggie Davis (Health Industry Distributors Association (HIDA));
Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 03/31/2026
Location: Raleigh, NC
Subject: Food Facility Inspections, Issues of Mutual Interest, and Lab Tour
FDA Participant/Group: ERIK METTLER;
Non FDA Participant/Group: North Carolina State Department of Agriculture and Consumer Services leadership and staff
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event
Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 03/31/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: 23andMe representatives
Event Date: 04/02/2026
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Verily representatives
Event Date: 04/03/2026
Location: Silver Spring, MD
Subject: Genaral Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Olympus representatives
Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research
Event Date: 04/03/2026
Location: Virtual
Subject: Hunter Syndrome Community Needs
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Denali Therapeutics representatives
Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine
No Significant Event